recombinant human cntf protein Search Results


recombinant human cntf  (R&D Systems)
94
R&D Systems recombinant human cntf
Recombinant Human Cntf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human cntf/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human cntf - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
ciliary neurotrophic factor  (Alomone Labs)
90
Alomone Labs ciliary neurotrophic factor
Ciliary Neurotrophic Factor, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ciliary neurotrophic factor/product/Alomone Labs
Average 90 stars, based on 1 article reviews
ciliary neurotrophic factor - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
trophic factors ciliary neuronotrophic factor cntf  (Alomone Labs)
91
Alomone Labs trophic factors ciliary neuronotrophic factor cntf
Trophic Factors Ciliary Neuronotrophic Factor Cntf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trophic factors ciliary neuronotrophic factor cntf/product/Alomone Labs
Average 91 stars, based on 1 article reviews
trophic factors ciliary neuronotrophic factor cntf - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
recombinant ciliary neurotrophic factor  (R&D Systems)
93
R&D Systems recombinant ciliary neurotrophic factor
Recombinant Ciliary Neurotrophic Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant ciliary neurotrophic factor/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant ciliary neurotrophic factor - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
ciliary neurotrophic factor  (R&D Systems)
93
R&D Systems ciliary neurotrophic factor
Ciliary Neurotrophic Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ciliary neurotrophic factor/product/R&D Systems
Average 93 stars, based on 1 article reviews
ciliary neurotrophic factor - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
ciliary neurotrophic factor cntf  (Alomone Labs)
91
Alomone Labs ciliary neurotrophic factor cntf
Ciliary Neurotrophic Factor Cntf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ciliary neurotrophic factor cntf/product/Alomone Labs
Average 91 stars, based on 1 article reviews
ciliary neurotrophic factor cntf - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
neurotrophic factor gdnf  (Boster Bio)
90
Boster Bio neurotrophic factor gdnf
Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34), which were significantly higher ( p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However, intermittent dASCs showed significantly higher P0 mRNA expression ( p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12) and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation ( p < 0.01) in comparison with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ± 5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher ( p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower ( p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e , f Brain-derived <t>neurotrophic</t> factor (BDNF) and glial cell line-derived neurotrophic factor <t>(GDNF)</t> secretion levels showed similar tendencies. The concentrations of BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher ( p < 0.01) than in the other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ± SEM. * p < 0.05, ** p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference, SC, Schwann cell
Neurotrophic Factor Gdnf, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neurotrophic factor gdnf/product/Boster Bio
Average 90 stars, based on 1 article reviews
neurotrophic factor gdnf - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
neurotrophic factor gdnf  (R&D Systems)
92
R&D Systems neurotrophic factor gdnf
Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34), which were significantly higher ( p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However, intermittent dASCs showed significantly higher P0 mRNA expression ( p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12) and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation ( p < 0.01) in comparison with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ± 5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher ( p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower ( p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e , f Brain-derived <t>neurotrophic</t> factor (BDNF) and glial cell line-derived neurotrophic factor <t>(GDNF)</t> secretion levels showed similar tendencies. The concentrations of BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher ( p < 0.01) than in the other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ± SEM. * p < 0.05, ** p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference, SC, Schwann cell
Neurotrophic Factor Gdnf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neurotrophic factor gdnf/product/R&D Systems
Average 92 stars, based on 1 article reviews
neurotrophic factor gdnf - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
chemicals cntf  (Alomone Labs)
91
Alomone Labs chemicals cntf
Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34), which were significantly higher ( p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However, intermittent dASCs showed significantly higher P0 mRNA expression ( p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12) and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation ( p < 0.01) in comparison with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ± 5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher ( p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower ( p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e , f Brain-derived <t>neurotrophic</t> factor (BDNF) and glial cell line-derived neurotrophic factor <t>(GDNF)</t> secretion levels showed similar tendencies. The concentrations of BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher ( p < 0.01) than in the other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ± SEM. * p < 0.05, ** p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference, SC, Schwann cell
Chemicals Cntf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chemicals cntf/product/Alomone Labs
Average 91 stars, based on 1 article reviews
chemicals cntf - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
recombinant human cntf protein  (Qiagen)
90
Qiagen recombinant human cntf protein
Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34), which were significantly higher ( p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However, intermittent dASCs showed significantly higher P0 mRNA expression ( p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12) and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation ( p < 0.01) in comparison with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ± 5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher ( p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower ( p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e , f Brain-derived <t>neurotrophic</t> factor (BDNF) and glial cell line-derived neurotrophic factor <t>(GDNF)</t> secretion levels showed similar tendencies. The concentrations of BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher ( p < 0.01) than in the other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ± SEM. * p < 0.05, ** p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference, SC, Schwann cell
Recombinant Human Cntf Protein, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human cntf protein/product/Qiagen
Average 90 stars, based on 1 article reviews
recombinant human cntf protein - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
recombinant human cntf protein  (Amgen)
90
Amgen recombinant human cntf protein
Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34), which were significantly higher ( p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However, intermittent dASCs showed significantly higher P0 mRNA expression ( p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12) and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation ( p < 0.01) in comparison with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ± 5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher ( p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower ( p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e , f Brain-derived <t>neurotrophic</t> factor (BDNF) and glial cell line-derived neurotrophic factor <t>(GDNF)</t> secretion levels showed similar tendencies. The concentrations of BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher ( p < 0.01) than in the other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ± SEM. * p < 0.05, ** p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference, SC, Schwann cell
Recombinant Human Cntf Protein, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human cntf protein/product/Amgen
Average 90 stars, based on 1 article reviews
recombinant human cntf protein - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34), which were significantly higher ( p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However, intermittent dASCs showed significantly higher P0 mRNA expression ( p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12) and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation ( p < 0.01) in comparison with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ± 5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher ( p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower ( p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e , f Brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) secretion levels showed similar tendencies. The concentrations of BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher ( p < 0.01) than in the other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ± SEM. * p < 0.05, ** p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference, SC, Schwann cell

Journal: Stem Cell Research & Therapy

Article Title: Differentiation of adipose-derived stem cells into Schwann cell-like cells through intermittent induction: potential advantage of cellular transient memory function

doi: 10.1186/s13287-018-0884-3

Figure Lengend Snippet: Relative messenger RNA (mRNA) expression and neurotrophin secretion levels of all groups. a The relative expression level of nerve growth factor receptor (NGFR) (p75) mRNA was not significantly different among sustaining dASCs 7d (5.55 ± 0.29), intermittent dASCs (5.11 ± 0.23), and SCs (5.54 ± 0.34), which were significantly higher ( p < 0.01) than the other three groups. b The relative expression level of P0 mRNA was highest in SCs (14.11 ± 0.88). There were no significant differences between intermittent dASCs (8.46 ± 0.34) and sustaining dASCs 7d (7.10 ± 0.54). However, intermittent dASCs showed significantly higher P0 mRNA expression ( p < 0.05) in comparison with sustaining dASCs 10d (6.00 ± 0.12) and 4d groups (2.66 ± 0.19). c The relative expression level of glial fibrillary acidic protein (GFAP) mRNA was not significantly different between intermittent dASCs (4.62 ± 0.21) and the three sustaining dASCs groups, all of which showed significant upregulation ( p < 0.01) in comparison with the undifferentiated adipose-derived stem cells (uASCs). d The levels of nerve growth factor (NGF) secreted by intermittent dASCs (99.37 ± 5.00 pg/ml) and sustaining dASCs 7d (95.20 ± 4.34 pg/ml) were significantly higher ( p < 0.01) than those of uASCs (31.18 ± 3.09 pg/ml), and sustaining dASCs 4d (54.69 ± 2.20 pg/ml) and 10d (45.90 ± 2.27 pg/ml), but lower ( p < 0.01) than that of SCs (112.46 ± 4.55 pg/ml). e , f Brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) secretion levels showed similar tendencies. The concentrations of BDNF and GDNF secreted by intermittent dASCs were 483.01 ± 10.08 and 205.66 ± 6.01 pg/ml, respectively, which were higher ( p < 0.01) than in the other groups, including SCs. g The concentrations tendency of ciliary neurotropic factor (CNTF) and NGF were similar. Data are expressed as means ± SEM. * p < 0.05, ** p < 0.01, one-way ANOVA with Tukey’s post-test or Dunnett’s T3 post-test. dASC, differentiated adipose-derived stem cell; n.s., no significant difference, SC, Schwann cell

Article Snippet: The concentrations of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and ciliary neurotrophic factor (CNTF) in the supernatant of each group were examined by ELISA using Rat NGF/NGF beta ELISA Kit (EK0471; Boster), Rat BDNF ELISA Kit (EK0308; Boster), Rat GDNF ELISA Kit (EK0363; Boster), and Rat CNTF ELISA Kit (EK0324; Boster), respectively.

Techniques: Expressing, Comparison, Derivative Assay